NAQC Newsroom: NAQC News

Connections-September

Thursday, September 15, 2022  
Posted by: Natalia Gromov

NAQC has posted the September issue of Connections, its monthly e-newsletter designed to keep members and partners connected to timely information about tobacco control, research, and upcoming events in the quitline community.

»view past issues

 
North American Quitline Consortium
September 2022

For quick navigation, please click on the titles below of the topics featured in this month's issue of Connections
Cessation and Tobacco Control News
Research
 
Tobacco CessationPriority PopulationsE-Cigarettes and Heated Tobacco ProductsTechnologyTobacco UseCOVID-19Job and Conference Announcements

Highlighted Article 

Cost-Sharing Partnership Initiative Orientation Video Series.
Cost-sharing partnerships can be a viable option for ensuring quitline sustainability and ensuring access to evidence-based services for all people wanting to quit tobacco. This initiative strives to provide states with the knowledge, resources, and technical assistance to successfully establish partnerships with both private and public insurers.

The first three videos in NAQC’s new orientation series on quitline cost-sharing partnerships are now online. Recordings are no more than 20 minutes in length,and include an Overview of the Cost-Sharing Partnership Process, a tutorial on the State Cessation Environmental Assessment Tool, and an Overview of Medicaid Partnership Options. Each video is accompanied by supporting resources.  

We would also like to remind you about the past webinar on Medicaid reimbursement for quitline pharmacy products which you find useful in partnership development. 
WEBINAR: Exploring Medicaid Reimbursement for Quitline Pharmacy Products
Learning Objectives:
  • Identify the potential barriers and solutions to pursuing Medicaid reimbursement for quitline pharmacy products.
  • Compare examples of state efforts to obtain Medicaid reimbursement for quitline pharmacy products.
  • Describe potential actions that state tobacco control programs can take to seek Medicaid reimbursement for quitline pharmacy products.
Slides
Presenter Bios
Recording

If you are interested in pursuing quitline cost-sharing partnerships, please contact Tracey Strader, Senior Program Manager at tstrader@naquitline.org for additional information, peer-to-peer support, and individual technical assistance.

NAQC News

September 22 at 1 to 4 pm ET: Advisory Council Meeting on Recommendations for Adult Vaping Cessation and Best and Promising Practices for Quitlines.
Join NAQC’s Advisory Council meeting to discuss recommendations on adult vaping cessation and prioritizing best and promising practices for quitlines. We will also ask for suggestions on topics NAQC should focus on in the coming year.
» register today

FY2022 Annual Survey of Quitlines Timeline. 
NAQC is pleased to share a draft timeline for the FY2022 Annual Survey of Quitlines. Please contact Katie Mason (kmason@naquitline.org) with any questions about or concerns with this timeline. We will be communicating additional information with quitlines and quitline service providers in upcoming weeks.

Wednesday, October 12th, 2022, 3 to 4:00 pm ET: FY2022 Annual Survey Training Webinar and FY2022 Annual Survey release.  The webinar announcement will be distributed shortly.

Thursday, December 22nd, 2021: Deadline for FY2022 Annual Survey completion

NAQC Membership FY2023 and Orientation/Refresher Webinar.Thank you to every organization and individual who renewed their NAQC membership or joined as a new member! For questions regarding membership, please contact Natalia Gromov at 800-398-5489 ext. 701 or membership@naquitline.org.

Join an orientation/refresher webinar to learn about existing programs and resources as well as about future projects.  Please contact Natalia Gromov at 800-398-5489 ext. 701 or membership@naquitline.org if you will be interested in attending. Please submit any priority question before the webinar so staff can address it.

 Find more NAQC News in our Newsroom or go back to top.



Time-Sensitive News

Webinar on September 20: Journey to a Tobacco-free Certified Community Behavioral Health Clinic (CCBHC): A Conversation.
Implementing evidence-based tobacco cessation approaches, including tobacco-free policies, in Certified Community Behavioral Health Clinic (CCBHC) treatment models can improve overall health outcomes.

Join the National Behavioral Health Network for Tobacco and Cancer Control and the Smoking Cessation Leadership Center, a National Center of Excellence for Tobacco-Free Recovery, on Tuesday, Sept. 20, 12:30-1:30 p.m. ET for an engaging discussion with two CCBHC leaders who will share the steps they took along their journey to implement a comprehensive tobacco-free policy within their organizations.

Participants who join the live session on Sept. 20 can earn one hour of free credit! You will receive instructions for claiming the credit in a post-webinar email.

By joining this webinar, you will:
•               Learn about the continuum of comprehensive tobacco control efforts in CCBHCs.
•               Understand the importance of tobacco-free CCBHCs.
•               Gain insights and strategies to implement tobacco-free policies.

» register today

SelfMade Health Network Webinar Series on Lung Cancer Disparities.
Part 1: Lung Cancer Disparities: Addressing Gaps and Opportunities to Improve Health Outcomes and Health Equity Among Low-Income Populations
Wednesday, September 21, 2022
 
Topics: Lung cancer disparities, health system evidence-based interventions (EBIs) to improve tobacco cessation and lung cancer screening rates among low-income patients and populations
 
Please register on the SelfMade Health Network (SMHN) website at: https://selfmadehealth.org/webcasts/
 
Part 2: Lung Cancer Disparities: Addressing Gaps and Opportunities to Improve Health Outcomes and Health Equity Among Low-Income Populations
Thursday, September 22, 2022
 
Topics include: Lung cancer disparities and screening eligibility criteria, tobacco cessation strategies following a lung cancer screening, as well as utilizing results from the American Lung Cancer “State of Lung Cancer Report” to improve community-clinical linkages
 
Please register on the SelfMade Health Network (SMHN) website at: https://selfmadehealth.org/webcasts/
 
Part 3: Lung Cancer Disparities: Addressing Gaps and Opportunities to Improve Health Outcomes and Health Equity Among Low-Income Populations
Wednesday, November 2, 2022
 
Topics include: Lung cancer screening disparities, health system evidence-based interventions (EBIs) to improve tobacco cessation, lung cancer screening and cancer survivorship as well as Medicaid coverage resources-lung cancer screening
 
Please register on the SelfMade Health Network (SMHN) website at: https://selfmadehealth.org/webcasts/

Workshop on September 28: Tobacco Cessation During Addiction Treatment.
You are invited to attend “Tobacco Cessation During Addiction Treatment” hosted by the American Society of Addiction Medicine (ASAM) on Wednesday, Sept. 28  from  2:30 pm – 4:45 pm ET. This is a  highly interactive workshop that will focus on the importance of integrating tobacco cessation treatment either simultaneously or sequentially during addiction treatment. Learners will explore how to provide effective nicotine withdrawal management when patients are admitted to withdrawal management and intensive inpatient centers. The skills include assessing levels of dependence, matching evidence based pharmacological and behavioral support to help patients achieve lasting remission without compromising their recovery journey and possibly enhancing recovery. Special focus on the integration in ambulatory OAT programs will be explored.  
» register today

September 29 CASTOR: Mitch Zeller Talk.
The Center for the Assessment of Tobacco Regulations [CAsToR ] s pleased to host the Former Director of the Center for Tobacco Products, United States Food and Drug Administration, Mr. Mitch Zeller, JD. Director Zeller will present on Thursday, September 29, 2022, 12:00 - 1:00 pm EDT, Rackham Amphitheatre, Ann Arbor MI.

Mr. Zeller will take an in-depth look at the historically unregulated marketplace for tobacco products and the public health consequences of the lack of regulation. He will then explore the critical role that the FDA plays in conducting premarket product reviews to determine whether new tobacco products are "appropriate for the protection of public health" and should be authorized for sale. He will close with a look forward, sharing observations and posing a series of questions related to the ongoing harm reduction debate surrounding e-cigarettes.

This event is free and open to the public.  A recording of the event will be posted on the CAsToR website following the event.
» register today

School of Medicine: University of CO Anschutz Medical Campus - Plan Now for the fall Tobacco Cessation Training Program!
Rocky Mountain Tobacco Treatment Specialist Training Program
October 10-13, 2022
The Rocky Mountain Tobacco Treatment Specialist (RMTTS) Training Program was developed to train interdisciplinary healthcare providers and community and public health professionals to become tobacco cessation champions for their organizations and communities. This program offers the highest quality tobacco treatment specialist training based on the latest evidence-based tobacco cessation research and treatment strategies.
 
The RMTTS Training Program provides a comprehensive, focused, and convenient process by which individuals can master the core competencies defined by the Association for the Treatment of Tobacco Use and Dependence and obtain the necessary training required to apply for the National Certificate in Tobacco Treatment Practice.
 
This program consists of an interactive, virtual 4-day training experience focused on providing the necessary knowledge, clinical skills, and evidence-based treatment strategies to effectively treat tobacco dependence.

Call for Abstracts Deadline of October 5: Seeking Innovations in Public Health.
Calling all change agents: Abstract submissions are now being accepted for the 2023 Agents of Change Summit. We invite you to share new tools, research, and strategies for improving health behaviors with your peers across public health, behavior change, and communications.
We are seeking evidence-based submissions for case studies, academic presentations, and sponsored breakout presentations that focus on any of the following health topics:

  • Tobacco & Vaping
  • Nutrition & Physical Activity
  • Substance Use Prevention
  • Cannabis Education and Youth Prevention
  • Sexual Health & Family Planning
  • Maternal Health & Early Childhood Development
  • Mental Health
  • Health Equity
  • Trust in Public Health and Government Agencies

Abstracts are due October 5, 2022, by midnight PT. Please share this call for abstracts with your colleagues and any thought leaders in the science and technology of public health and behavior change.
» learn more

Deadline of October 12 - Truth Initiative Grant Opportunity for Colleges.
The Truth Initiative Tobacco/Vape-Free College Program is offering grants of up to $20,000 to colleges and universities to support the adoption and implementation of a 100% tobacco/vape free policy. Grantees will receive technical assistance through an in-person training, webinars and one-on-one consultations throughout the grant period. They will also receive programming for student activism and evidence-based cessation for students and employees.  

Since 2015, the Truth Initiative Tobacco/Vape-Free College Program has provided grants to more than 200 minority-serving institutions, community colleges, women’s colleges and college systems. This is the first year that Truth Initiative will be expanding the grant to all colleges and universities that do not already have a 100% smoke- or tobacco/vape-free campus policy. The grant expansion is a response to the burden of the vaping epidemic, COVID-19, and the mental health crisis of this generation. Students are facing more mental health issues today than any other generation. One in five college students say their mental health has significantly worsened due to COVID-19. Vaping nicotine can amplify feelings of depression and anxiety symptoms. A tobacco/vape-free policy is a critical component of an overall plan to promote campus health and well-being. With 99% of smokers starting before age 26, college campuses are critical to preventing young adults from starting tobacco use, aiding current smokers in quitting and reducing exposure to secondhand smoke for all. 

Colleges that have smoke- or tobacco-free policies that do not include e-cigarettes may still apply. To combat the vaping epidemic, Truth Initiative is offering grants of up to $10,000 to colleges to strengthen their 100% smoke or tobacco-free policies by adding e-cigarettes.

For more information, including the grant guidelines, link to the online application and informational webinar registration, please visit: https://truthinitiative.org/tobacco-vape-free-college-program. Please direct questions to Vera Kuma at vkuma@truthinitiative.orgThe deadline to apply is October 12, 2022, at 5:00 p.m. ET.

November 8 and 9: Continuing Education Credits & Certification in Nicotine Dependence Treatment.

THE UNIVERSITY OF ARIZONA, Tucson in AZ.
11/8: Basic Tobacco Intervention Skills
11/9: INSTRUCTOR Basic Tobacco Intervention Skills
Certification for Medical & Allied Health Professionals
UPDATES reflect current trends and statistics in Nicotine Addiction and Treatment Intervention. 
NEW CONTENT
•      Electronic Nicotine Delivery Systems (ENDS)
•      Low-dose CT (LDCT) lung cancer screening for early detection
•      Social Determinants linked to higher tobacco use

» register today

Find more Time-Sensitive News in our Newsroom or go back to top.


Cessation and Tobacco Control News


"Back to School" with SCLC Webinar Bundles--FREE CME/CEUs Available for Providers!
Collection C: This Collection of recorded webinars from SCLC includes 11 webinars, for a total of 11.5 CE credits. Topics include the stigma of smoking, the homeless population and tobacco use, assisting clients to quit smoking, taking campuses tobacco-free, the harms of menthol, leveraging quitlines to help behavioral health patients quit, smoke-free public housing, systems change, adding tobacco cessation services to treatment plans, tobacco and cancer research, and re-framing tobacco in the behavioral health population. Read more and register for this collection 

Collection D: This Collection of recorded webinars from SCLC includes seven webinars, for a total of 12.0 CE credits. Topics include COVID-19 and the effects of tobacco use, I COVID Quit - personal stories, IQOS, digital cessation, recovery-oriented tobacco interventions in addiction services, tobacco cessation with adult inpatient psychiatric clients, and e-cigarettes and smoking cessation. Read more and register for this collection 

Please use the discount code SAMHSA23 to waive the registration fee. 
 
Physicians, Pharmacists, Nurse Practitioners, Psychologists, LMFTs, LCSWs, Addiction Counselors and more! 
» learn more

K-PACT Tobacco Treatment Training for Perinatal Providers.
The University of Kentucky Perinatal Research and Wellness Center has been collaborating with the Kentucky Opioid Response Effort (KORE) to create K-PACT(Kentucky Perinatal Action for Concurrent Tobacco Treatment), which is a Tobacco Treatment Training for Perinatal Providers—any individuals who provide care to pregnant women and/or women of childbearing age are considered providers:  doctors, nurses, nurse practitioners, midwives, social workers, case managers, recovery specialists, medical assistants, peer support specialists, etc.  While there are some statistics specific to the state of Kentucky, the information is applicable to all perinatal providers; to date, 80 providers from a variety of professions and 18 different states have completed the training.
 
Here are some highlights of the program:
K-PACT Tobacco Treatment Training for Perinatal Providers
  • 4 self-paced modules
  • Topics:  
    • Basics of tobacco treatment, 
    • Electronic Nicotine Delivery Systems (ENDS), 
    • Concurrent tobacco and substance use, 
    • Get Fit and Quit (behavioral modification to assist with quitting)
  • Time for completion = About 4 hours total
  • CE Credits:  4.0 (AMA and ANCC) FREE
  • Includes:  Printable resources, brief videos and animations, up-to-date statistics, pharmacotherapy guidance, billing codes, and simple tips to use when talking with women about cessation
  • Link: https://www.cecentral.com/K-PACT
  • Additional Support:  COMING THIS FALL!!!  Our team will be releasing an online, tobacco cessation “storybook” designed specifically for women!  This platform will provide education as women personalize their own QUIT JOURNEY.  When released, it will be found at www.quitforus.com!  

Time, expertise, and confidence are often barriers to delivering tobacco cessation guidance, particularly amidst substance use recovery, but quitting smoking during recovery increases the chance of long term sobriety by 25%!!!  And smoking is the single most modifiable risk factor for poor pregnancy outcome!  
 
Please direct questions to Janine Barnett at Janine.zabroski@uky.edu or 859-333-1572.
 
Public Health Law Center Releases 50-State Scan of Tobacco Dependency Treatment Requirements.
The Public Health Law Center has just released an overview of U.S. state laws requiring mental health and substance use facilities to provide tobacco dependency treatment in clinical practice. This resource, which includes links to state tobacco dependency treatment laws, relevant definitions, online resources, and related information, is a working document that will continue to be updated.
» learn more

New CDC Feature Article Highlights Health Equity and the Importance of Improving Tobacco-Related Health Disparities. 
new CDC feature article highlights health equity, including the opportunity to be free from commercial tobacco. More protections are needed to prevent tobacco use and secondhand smoke exposure among different population groups, and to help people who use tobacco to quit smoking for good. Everyone deserves to be as healthy as they can be, and that means living free from the harmful effects of commercial tobacco. By addressing social determinants of health, including those related to targeted marketing and barriers to healthcare, states and communities can move toward health equity and reduce health disparities.    
» learn more

LGBTQ+ Tobacco Use New Issue Brief.
The University of Michigan Tobacco Research Network has developed a new issue brief focused on tobacco use among LGBTQ+ individuals. This resource is intended to help organizations offer more supportive, affirming, and effective tobacco prevention and cessation programs for LGBTQ+ individuals. It features recent data from surveys and focus groups with Michigan LGBTQ+ individuals.
» learn more

Juul’s Multi-million-dollar Settlement is an Opportunity to Accelerate Progress Through Proven-effective Youth Prevention and Quit Vaping Programs.
Truth Initiative applauds the actions of the state attorneys general of 34 states and territories, which if finalized, will result in Juul, owned in part by tobacco giant Altria, being held financially accountable for igniting the ongoing youth e-cigarette epidemic via their aggressive, youth targeted marketing of its high-nicotine products.
» learn more

What is “Tobacco-free” Nicotine?
Some nicotine-containing products in sweet and fruity flavors – e-cigarettes, pouches, lozenges, and even gummies – are marketed as containing “tobacco-free nicotine.” These flavored products, which have yet to face significant regulation, are prompting concerns about youth use and causing confusion.
» learn more

Find more Cessation and Tobacco Control News in our Newsroom or go back to top.


Research

Tobacco Cessation

Reddy KP, Kruse GR, Lee S, Shuter J, Rigotti NA.
Tobacco Use and Treatment of Tobacco Dependence among People with Human Immunodeficiency Virus: A Practical Guide for Clinicians.
Clin Infect Dis. 2022;75(3):525-533. doi:10.1093/cid/ciab1069

More than 40% of people with human immunodeficiency virus (PWH) in the United States smoke tobacco cigarettes. Among those on antiretroviral therapy, smoking decreases life expectancy more than human immunodeficiency virus (HIV) itself. Most PWH who smoke want to quit, but tobacco dependence treatment has not been widely integrated into HIV care. This article summarizes the epidemiology of tobacco use among PWH, health consequences of tobacco use and benefits of cessation in PWH, and studies of treatment for tobacco dependence among the general population and among PWH. We provide practical guidance for providers to treat tobacco dependence among PWH. A 3-step Ask-Advise-Connect framework includes asking about tobacco use routinely during clinical encounters, advising about tobacco cessation with emphasis on the benefits of cessation, and actively connecting patients to cessation treatments, including prescription of pharmacotherapy (preferably varenicline) and direct connection to behavioral interventions via telephone quitline or other means to increase the likelihood of a successful quit attempt.

Priority Populations

Clawson AH, Cole AB, Ruppe NM, et al.
Smoking Across Adolescence and Adulthood with Cardiovascular Risk among American Indian Peoples.
[published online ahead of print, 2022 Sep 1]. Health Psychol. 2022;10.1037/hea0001227. doi:10.1037/hea0001227

Objective. American Indian peoples (AIs) have high smoking rates and cardiovascular risk factor burden. The present study aimed to (a) investigate latent smoking classes across adolescence and adulthood, (b) investigate adolescent predictors of smoking classes, and (c) assess how smoking class is related to adult cardiovascular risk in a sample of AIs.
Method. A sample of AIs (N = 338) from the National Adolescent to Adult Health Study self-reported on smoking across four assessment waves (W1: 7th-12th grade; W2: 8th-12th grade; W3: ages 18-26; W4: ages 24-32). The socioecological framework for addressing tobacco-related disparities was used to identify potential adolescent (W1) risk and resource factors. C-reactive protein, blood pressure, and lipids were collected at W4. Growth mixture modeling and regressions were used.
Results. Six smoking classes were identified: light smoking (36%), nonsmoking (23%), escalating, adult daily smoking (13%), chronic heavy smoking (12%), escalating, young adult daily smoking (9%), and reducing smoking (7%). Risk factors for being in the chronic heavy smoking class included peer smoking and older age at W1. Compared with the chronic heavy smoking class, AIs in the reducing smoking class lived in in more impoverished neighborhoods during adolescence. Relative to several classes with less smoking, being in the chronic heavy smoking class was associated with higher C-reactive protein and less favorable lipid levels. W1 social support was a resource factor for adult diastolic blood pressure and some lipids.
Conclusions. Socioecologically informed tobacco interventions have the potential to reduce smoking and cardiovascular risk among AIs, and bolstering social support may be important. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Subica AM, Guerrero EG, Martin TKK, et al.
Native Hawaiian/Pacific Islander Alcohol, Tobacco and Other Drug Use, Mental Health and Treatment Need in the United States During COVID-19.
[published online ahead of print, 2022 Aug 11]. Drug Alcohol Rev. 2022;10.1111/dar.13522. doi:10.1111/dar.13522

Introduction. Before COVID-19, Native Hawaiians/Pacific Islanders (NH/PI) endured a heavy burden of alcohol, tobacco and other drug (ATOD) use in prior US data. Responding to reports that many NH/PI communities experienced severe COVID-19 disparities that could exacerbate their ATOD burden, we partnered with NH/PI communities to assess the substance use patterns and treatment needs of diverse NH/PIs during COVID-19.
Methods. Collaborating with NH/PI community organisations across five states with large NH/PI populations, we conducted a large-scale investigation of NH/PI ATOD use, mental health and treatment need during COVID-19. Between April and November 2021, NH/PI-heritage research staff from our community partners collected data involving 306 NH/PI adults using several community-based recruitment methods (e-mail, telephone, in-person) and two survey approaches: online and paper-and-pencil. Multivariate regressions were conducted to examine potential predictors of NH/PI alcohol use disorder and need for behavioural health treatment.
Results. During COVID-19, 47% and 22% of NH/PI adults reported current alcohol and cigarette use, while 35% reported lifetime illicit substance use (e.g., cannabis, opioid). Depression and anxiety were high, and alcohol use disorder, major depression and generalised anxiety disorder prevalence were 27%, 27% and 19%, respectively. One-third of participants reported past-year treatment need with lifetime illicit substance use, COVID-19 distress and major depression respectively associating with 3.0, 1.2, and 5.3 times greater adjusted odds for needing treatment.
Conclusions. NH/PI adults reported heavy ATOD use, depression, anxiety and treatment need during COVID-19. Targeted research and treatment services may be warranted to mitigate COVID-19's negative behavioural health impact on NH/PI communities.

Bailey SR, Hwang J, Marino M, et al.
Smoking-cessation Assistance among Older Adults by Ethnicity/Language Preference.
Am J Prev Med. 2022;63(3):423-430. doi:10.1016/j.amepre.2022.03.024

Introduction. Although smoking prevalence is lower among Hispanic adults than among non-Hispanic White adults, smoking remains a leading cause of preventable death among older Hispanics. This study examines the differences in tobacco assessment and smoking-cessation assistance among older patients seen in community health centers by ethnicity and language preference.
Methods. Electronic health record data were extracted from the Accelerating Data Value Across a National Community Health Center Network of community health centers from patients aged 55‒80 years with ≥1 primary care visit between January 1, 2017 and December 31, 2018. Binary outcomes included tobacco use assessment and, among those with ≥1 status indicating current smoking, having a smoking-cessation medication ordered. The independent variable combined ethnicity and language preference, categorized as non-Hispanic White (reference), Spanish-preferring Hispanic, and English-preferring Hispanic. Multivariable generalized estimating equation logistic regressions, clustering by primary care clinic using an exchangeable working correlation structure, modeled the odds of tobacco use assessment and cessation medication orders by ethnicity/preferred language, adjusting for patient covariates, health system, and clinic location. Analyses were conducted in 2021.
Results. The study included 116,328 patients. Spanish-preferring Hispanic patients had significantly lower odds of having tobacco use assessed than non-Hispanic White patients (AOR=0.89, 95% CI=0.82, 0.95). Both Spanish- and English-preferring Hispanic patients had lower odds of having a smoking-cessation medication ordered (AOR=0.53, 95% CI=0.47, 0.60; AOR=0.77, 95% CI=0.67, 0.89, respectively) than non-Hispanic White patients.
Conclusions. Significant disparities were found in tobacco assessment and cessation assistance by ethnicity and language preference among older adults seen in safety-net clinics. Future research is needed to understand the etiology of these smoking-related disparities.

E-Cigarettes and Heated Tobacco Products 

Banks E, Martin M, Harris M.
Framework for the Public Health Assessment of Electronic Cigarettes.
Tob Control. 2022;31(5):608-614. doi:10.1136/tobaccocontrol-2020-056271

Background. Electronic cigarettes (e-cigarettes) are relatively new products with substantial public health impacts. Evidence on their effects is diverse and emerging rapidly, presenting challenges to high-quality policymaking and decision-making. This paper addresses these challenges by developing and presenting a framework for the public health assessment of e-cigarettes, using the Australian context as an example.
Methods. Framework development involved stakeholder engagement, development of guiding principles, and consideration of existing relevant frameworks and the evidence requirements of current policy options, identified in published and grey literature.
Results. Guiding principles include the need for the framework to: be evidence based; include consideration of the likely balance of benefits and risks of e-cigarettes, uncertainty and safety; support equity; support the ongoing application of evidence to high-quality policy and practice; and consider potential competing interests. The framework draws upon: health technology assessment; health impact assessment; environmental health risk assessment; healthcare recommendations evidence evaluation; consumer goods regulation; medicine and chemical scheduling; tobacco product evaluation; previous reviews and the precautionary principle. Final framework components are: (1) characterisation of products under consideration; (2) definition of populations of interest; (3) characterisation of tobacco smoking, control and impacts on health and well-being; (4) review of evidence on patterns of e-cigarette use; (5) review of evidence on e-cigarette use and health outcomes; (6) assessment of likely risks, benefits and safety; (7) identification and assessment of policy options to optimise health outcomes.
Conclusions. Structured and ongoing public health assessment of e-cigarette use is likely to support health through enhancing evidence-based decision-making.

Ozga JE, Stroup AM, Abadi MH, et al.
E-cigarette Marketing Expenditures in the U.S. from 2016-2021: Targeted Media Outlets Geared Toward People who are at Increased Risk for Tobacco Use.
[published online ahead of print, 2022 Sep 7]. Nicotine Tob Res. 2022;ntac209. doi:10.1093/ntr/ntac209

Introduction. E-cigarette advertising exposure is linked to e-cigarette initiation and use. Thus, monitoring trends in e-cigarette advertising practices is important to understand e-cigarette use patterns observed over recent years.
Methods. E-cigarette advertising expenditures (January 2016-July 2021; Numerator Ad Intel) for 154 U.S. market areas were harmonized with U.S. Census sociodemographic data through Nielsen market area/zip code designations. Descriptive statistics and multivariable linear regressions were used to examine trends in e-cigarette advertising expenditures across media outlets and associations between sociodemographic characteristics and e-cigarette advertising over time.
Results. E-cigarette advertising expenditures peaked in 2018/2019, followed by a sharp decline in 2020. Expenditures were concentrated primarily on print (58.9%), TV (20.6%) and radio (14.4%). Major print outlets were Sports Illustrated, Rolling Stone, and Star magazines. Top TV channels were AMC, Investigation Discovery, and TBS. TV advertisements were purchased commonly during popular movies/series (e.g., King of Queens, Everybody Loves Raymond, The Walking Dead). Higher expenditures were associated with U.S. market areas that had (a) a larger percentage of non-rural zip codes (radio), (b) smaller male populations (radio), and (c) larger White/Caucasian, Black/African American, American Indian/Alaska Native, Asian, and Other/Multiracial populations (radio, print, online display, online video).
Conclusions. E-cigarette companies advertised in print magazines geared toward males and youth/young adults, radio commercials focused in urban areas with smaller male populations, and nationwide TV commercials. Declines in e-cigarette advertising expenditures in 2020 demonstrate the potential impact that federal policies may have on protecting populations who are at higher risk for tobacco use from predatory advertising practices.
Implications. E-cigarette advertising exposure is associated with initiation and use of e-cigarettes. This study shows how e-cigarette marketing expenditures in the U.S. may have targeted specific consumers (e.g., youth/young adults) between 2016 and 2021. The precipitous drop in advertising expenditures across all outlets during early 2020 corresponds with the implementation of the Tobacco 21 federal policy, the federal enforcement policy to remove most unauthorized flavored e-cigarette cartridges from the U.S. market, preparations for FDA's premarket review of e-cigarette products, and the decision by several TV broadcast companies to stop showing e-cigarette ads. The potential impact of federal policies may have far-reaching implications for protecting populations who are at high risk for tobacco use and its health consequences.

Perry RN, Girgulis JP, Harrison SL, Barrett SP.
Dual Users' Perceptions of the Addictive Properties of Cigarettes Versus E-cigarettes.
[published online ahead of print, 2022 Sep 3]. Addict Behav. 2022;136:107483. doi:10.1016/j.addbeh.2022.107483

Introduction. Electronic cigarettes ("e-cigarettes") are commonly promoted as a less-harmful alternative to combustible cigarettes, yet many individuals concurrently use both products ("dual users"). Little is known about the extent to which dual users' perceptions of the addictive properties of these products differ, or to what extent there are differences in the factors that elicit craving for each product.
Methods. An online survey evaluated beliefs about the addictive properties of cigarettes vs e-cigarettes and the situational and affective precipitants of product craving, on a scale from 1 to 10, in a sample of Canadian adults that reported past-month use of combustible and e-cigarettes (N = 175; 79 female).
Results. Participants rated cigarettes as more addictive than e-cigarettes, and on average reported higher levels of dependence on combustible cigarettes. While the addictive properties of both combustible and e-cigarettes were largely attributed to nicotine, non-nicotine factors (e.g. flavouring, other non-nicotine ingredients) were believed to make a relatively stronger contribution to the addictive properties of e-cigarettes, particularly among women. Participants reported greater increases in craving for combustible cigarettes in response to negative affective states and situational factors, and these effects were strongest among participants that displayed greater dependence on combustible tobacco relative to e-cigarettes.
Conclusions. Dual users perceived cigarettes to be more addictive than e-cigarettes and attributed the addictive properties of each product to different factors. Further, cravings for combustible cigarettes were more strongly linked to certain negative affective states and situational factors relative to e-cigarettes. Findings suggest that there may be limited substitutability between combustible and e-cigarettes.

Gaiha SM, Henriksen L, Halpern-Felsher B, et al.
Sources of Flavoured E-cigarettes among California Youth and Young Adults: Associations with Local Flavoured Tobacco Sales Restrictions.
Tob Control. 2022;31(5):659-662. doi:10.1136/tobaccocontrol-2020-056455

Purpose. This study compares access to flavoured JUUL and other e-cigarettes from retail, online and social sources among underage and young adult e-cigarette users who live in California jurisdictions that restrict sales of flavoured tobacco with the rest of the state.
Methods. An online survey used social media advertisements to recruit participants (n=3075, ages 15-29) who lived in one of nine jurisdictions that restrict sales (n=1539) or in the rest of state, and oversampled flavoured tobacco users. Focusing on past-month e-cigarette users (n=908), multilevel models tested whether access to flavoured JUUL and other e-cigarettes from retail, online and social sources differed by local law (yes/no) and age group (15-20 or older), controlling for other individual characteristics.
Results. The percent of underage users who obtained flavoured JUUL and other e-cigarettes in the past month was 33.6% and 31.2% from retail, 11.6% and 12.7% online, and 76.0% and 70.9% from social sources, respectively. Compared with underage and young adult users in the rest of California, those in localities that restrict the sales of flavoured tobacco were less likely to obtain flavoured JUUL from retail sources (Adjusted OR=0.54, 95% CI 0.36 to 0.80), but more likely to obtain it from social sources (Adjusted OR=1.55, 95% CI 1.02 to 2.35). The same pattern was observed for other brands of flavoured e-cigarettes.
Conclusion. Although local laws may reduce access to flavoured e-cigarettes from retail sources, more comprehensive state or federal restrictions are recommended to close the loopholes for online sources. Dedicated efforts to curtail access from social sources are needed.

Technology

Bricker JB, Mull KE, Santiago-Torres M, Miao Z, Perski O, Di C.
Smoking Cessation Amartphone App Use Over Time: Predicting 12-month Cessation Outcomes in a 2-Arm Randomized Trial.
J Med Internet Res. 2022;24(8):e39208. Published 2022 Aug 18. doi:10.2196/39208

Background. Little is known about how individuals engage over time with smartphone app interventions and whether this engagement predicts health outcomes.
Objective. In the context of a randomized trial comparing 2 smartphone apps for smoking cessation, this study aimed to determine distinct groups of smartphone app log-in trajectories over a 6-month period, their association with smoking cessation outcomes at 12 months, and baseline user characteristics that predict data-driven trajectory group membership.
Methods. Functional clustering of 182 consecutive days of smoothed log-in data from both arms of a large (N=2415) randomized trial of 2 smartphone apps for smoking cessation (iCanQuit and QuitGuide) was used to identify distinct trajectory groups. Logistic regression was used to determine the association of group membership with the primary outcome of 30-day point prevalence of smoking abstinence at 12 months. Finally, the baseline characteristics associated with group membership were examined using logistic and multinomial logistic regression. The analyses were conducted separately for each app.
Results. For iCanQuit, participants were clustered into 3 groups: "1-week users" (610/1069, 57.06%), "4-week users" (303/1069, 28.34%), and "26-week users" (156/1069, 14.59%). For smoking cessation rates at the 12-month follow-up, compared with 1-week users, 4-week users had 50% higher odds of cessation (30% vs 23%; odds ratio [OR] 1.50, 95% CI 1.05-2.14; P=.03), whereas 26-week users had 397% higher odds (56% vs 23%; OR 4.97, 95% CI 3.31-7.52; P<.001). For QuitGuide, participants were clustered into 2 groups: "1-week users" (695/1064, 65.32%) and "3-week users" (369/1064, 34.68%). The difference in the odds of being abstinent at 12 months for 3-week users versus 1-week users was minimal (23% vs 21%; OR 1.16, 95% CI 0.84-1.62; P=.37). Different baseline characteristics predicted the trajectory group membership for each app.
Conclusions. Patterns of 1-, 3-, and 4-week smartphone app use for smoking cessation may be common in how people engage in digital health interventions. There were significantly higher odds of quitting smoking among 4-week users and especially among 26-week users of the iCanQuit app. To improve study outcomes, strategies for detecting users who disengage early from these interventions (1-week users) and proactively offering them a more intensive intervention could be fruitful.

Villanti AC, Peasley-Miklus C, Cha S, et al.
Tailored Text Message and Web Intervention for Smoking Cessation in U.S. Socioeconomically-Disadvantaged Young Adults: A Randomized Controlled Trial.
[published online ahead of print, 2022 Aug 19]. Prev Med. 2022;107209. doi:10.1016/j.ypmed.2022.107209

The prevalence of cigarette smoking in young adults is higher among those with socioeconomic disadvantage than those without. Low treatment-seeking among young adult smokers is compounded by few efficacious smoking cessation interventions for this group, particularly socioeconomically-disadvantaged young adults (SDYA) who smoke cigarettes. The goal of this study was to test a tailored smoking-cessation intervention for SDYA. 343 SDYA aged 18-30 living in the U.S. (85% female) who smoke cigarettes with access to a smartphone and interest in quitting smoking in the next six months were recruited online in Spring 2020 and randomized to referral to online quit resources (usual care control; n = 171) or a 12-week tailored text message smoking-cessation program with a companion web-based intervention (n = 172). Intent to treat analyses examined associations between study condition, self-reported 30-day point prevalence abstinence (PPA), and confidence to quit smoking at 12 weeks, controlling for potential confounders. Intervention group participants had greater self-reported 30-day PPA at 12-weeks than controls (adjusted relative risk 3.93, 95% CI 2.14-7.24). Among those who continued smoking, the intervention increased confidence to quit (0.81 points, 95% confidence interval 0.08-1.53). Weekly engagement in the intervention predicted greater cessation. A tailored text message intervention for SDYA increased smoking abstinence and confidence to quit at the end-of-treatment. Findings may have been influenced by recruitment at the start of the COVID pandemic but suggest that text messaging is an acceptable and efficacious cessation strategy for SDYA smokers. Future studies should examine the impact on longer-term smoking-cessation and importance of intervention tailoring for SDYA.

Kathuria H, Shankar D, Cobb V, et al.
Integrating Social Determinants of Health with Tobacco Treatment for Individuals with Opioid Use Disorder: Feasibility and Acceptability Study of Delivery Through Text Messaging.
JMIR Form Res. 2022;6(9):e36919. Published 2022 Sep 1. doi:10.2196/36919

Background. Individuals with opioid use disorder (OUD) have a high prevalence of smoking and frequently experience unmet social determinants of health (SDOH), which may be barriers to smoking cessation. Hospitalization is an opportunity to encourage smoking cessation. Unfortunately, many clinicians do not provide tobacco treatment to support the maintenance of cessation achieved during hospitalization. Interventions are required to support these high-risk individuals after hospital discharge.
Objective. This study aimed to test the feasibility and acceptability of a 28-day SMS text messaging program tailored to individuals with OUD, which provides smoking cessation support and addresses unmet SDOH needs.
Methods. From July to December 2019, we enrolled 25 individuals who were hospitalized with tobacco dependence and OUD at our large safety net hospital. The SMS text messaging program was initiated during hospitalization and continued for 28 days. Participants were enrolled in either the ready to quit within 30 days or the not ready to quit within 30 days program based on their readiness to quit. Automated SMS text messages were sent twice daily for 4 weeks. The topics included health and cost benefits of quitting, both general and opioid specific (16 messages); managing mood and stress (8 messages); motivation, coping strategies, and encouragement (18 messages); addressing medication misconceptions (5 messages); links to resources to address substance use (2 messages providing links to the Massachusetts Substance Use Helpline and Boston Medical Center resources), tobacco dependence (1 message providing a link to the Massachusetts Quitline), and unmet SDOH needs (6 messages assessing SDOH needs with links to resources if unmet SDOH needs were identified). Questionnaires and interviews were conducted at baseline and at 2 and 4 weeks after enrollment.
Results. The participants were 56% (14/25) female, 36% (9/25) African American, 92% (23/25) unemployed, and 96% (24/25) Medicaid insured. Approximately 84% (21/25) activated the program, and none of the participants unsubscribed. Approximately 57% (12/21) completed either the 2- or 4-week questionnaires. Program satisfaction was high (overall mean 6.7, SD 0.8, range 1-7). Many perceived that the SMS text messaging program provided social support, companionship, and motivation to stop smoking. Messages about the health benefits of quitting were well received, whereas messages on how quitting cigarettes may prevent relapse from other substances had mixed views, highlighting the importance of tailoring interventions to patient preferences.
Conclusions. SMS text messaging to promote smoking cessation and address SDOH needs may be an effective tool for improving quit rates and health outcomes in individuals with tobacco dependence and OUD. Our study adds to the growing body of evidence that SMS text messaging approaches are feasible and acceptable for providing tobacco treatment to all individuals who smoke, even among low-income populations who have OUD and are not ready to quit.

Tobacco Use

Donaldson SI, Dormanesh A, Perez C, Majmundar A, Allem JP.
Association Between Exposure to Tobacco Content on Social Media and Tobacco Use: A Systematic Review and Meta-analysis.
JAMA Pediatr. 2022;176(9):878-885. doi:10.1001/jamapediatrics.2022.2223

Importance. Exposure to tobacco-related content on social media may foster positive attitudes toward tobacco products and brands, and influence the likelihood of initiating or continuing use of tobacco, especially among adolescents and young adults.
Objective. To perform the first systematic review and meta-analysis, to our knowledge, on studies that examined the association between exposure to tobacco content on social media and lifetime tobacco use, past 30-day tobacco use, and susceptibility to use tobacco among never users.
Data sources. Tobacco, social media, and marketing search terms were entered into online databases, including MEDLINE, ISI Web of Science, Scopus, and PsychINFO. Study characteristics, including research design and methods, sampling strategy, and demographics, were assessed for each study.
Study selection. Studies reporting odds ratios (ORs) for self-reported exposure to, or experimentally manipulated, tobacco content on social media and lifetime tobacco use, past 30-day tobacco, and susceptibility to use tobacco among never users. The systematic search produced 897 independent articles, of which 29 studies met inclusion criteria.
Data extraction and synthesis. A 3-level random-effects meta-analysis was used to estimate ORs, 95% CIs, and heterogeneity (I2) for each tobacco use outcome. Study quality and publication bias were assessed.
Main outcomes and measures. Lifetime tobacco use, past 30-day tobacco use, and susceptibility to use tobacco among never users. Tobacco use included e-cigarettes, cigarettes, and other (cigar, hookah, smokeless tobacco).
Results. The total sample size across the 24 included datasets was 139 624, including 100 666 adolescents (72%), 20 710 young adults (15%), and 18 248 adults (13%). Participants who were exposed to tobacco content on social media, compared with those who were not exposed, had greater odds of reporting lifetime tobacco use (OR, 2.18; 95% CI, 1.54-3.08; I2 = 94%), past 30-day tobacco use (OR, 2.19; 95% CI, 1.79-2.67; I2 = 84%), and susceptibility to use tobacco among never users (OR, 2.08; 95% CI, 1.65-2.63; I2 = 73%). Subgroup analyses showed similar associations for tobacco promotions, active engagement, passive engagement, lifetime exposure to tobacco content, exposure to tobacco content on more than 2 platforms, and exposure to tobacco content among adolescents and young adults.
Conclusions and relevance. Findings suggest that a comprehensive strategy to reduce the amount of tobacco content on social media should be developed by federal regulators. Such actions may have downstream effects on adolescent and young adult exposure to protobacco content, and ultimately tobacco use behaviors.

Powers JM, Maisto SA, Zvolensky MJ, Heckman BW, Ditre JW.
Longitudinal Associations Between Pain and Use of Cigarettes and E-cigarettes in the Population Assessment of Tobacco and Health (PATH) Study.
[published online ahead of print, 2022 Aug 15]. Nicotine Tob Res. 2022;ntac197. doi:10.1093/ntr/ntac197

Introduction. Pain has been implicated in the onset and maintenance of nicotine addiction, and there is initial cross-sectional evidence of covariation between pain and use/co-use of cigarettes and e-cigarettes. The goals of the current study were to: (1) test pain severity as a predictor of initiating co-use of cigarettes/e-cigarettes; (2) examine longitudinal associations between pain and use/co-use of cigarette and e-cigarettes; (3) generate the first prevalence rate data regarding cigarette and/or e-cigarette use as a function of pain; and (4) examine gender as a moderator of these associations.
Methods. Data were drawn from Waves 1-4 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2018).
Results. Among exclusive cigarette smokers at Wave 1 (n = 7,719), pain severity was associated with greater likelihood of and faster trajectory to initiating co-use of cigarettes/e-cigarettes (ps < .05). A significant pain x gender interaction (p < .05) revealed this prospective relationship was stronger among women. Among adult respondents who provided at least three waves of data (n = 24,255), greater Wave 1 pain severity was positively associated with e-cigarette use, cigarette smoking, and co-use of cigarettes/e-cigarettes at Waves 2, 3, and 4 (ps < .001). At Wave 4 (n = 33,822), adults with moderate/severe pain endorsed rates of e-cigarette and cigarette use/co-use almost two times greater versus no/low pain (ps < .001).
Conclusions. Collectively, these findings provide evidence that pain likely serves as an important candidate risk factor for the initiation and maintenance of cigarette and e-cigarette use.
Implications. This is the first prospective study to show that pain serves as an important risk factor for initiation and maintenance of cigarette and e-cigarette use/co-use over time. Weighted prevalence estimates further demonstrated that individuals with moderate/severe pain endorsed rates of cigarette and e-cigarette use/co-use approximately two times greater compared to those with no/low pain. These findings highlight a subpopulation of nicotine users more susceptible to greater health-care burden, nicotine dependence, and physical impairment. Nicotine users with comorbid pain may benefit from integrated interventions that address pain in the context of cessation.

COVID-19

Benowitz NL, Goniewicz ML, Halpern-Felsher B, et al.
Tobacco Product Use and the Risks of SARS-CoV-2 Infection and COVID-19: Current Understanding and Recommendations for Future Research.
Lancet Respir Med. 2022;10(9):900-915. doi:10.1016/S2213-2600(22)00182-5

Heterogeneity in the clinical presentation of SARS-CoV-2 infection and COVID-19 progression underscores the urgent need to identify individual-level susceptibility factors that affect infection vulnerability and disease severity. Tobacco product use is a potential susceptibility factor. In this Personal View, we provide an overview of the findings of peer-reviewed, published studies relating tobacco product use to SARS-CoV-2 infection and COVID-19 outcomes, with most studies focusing on cigarette smoking in adults. Findings pertaining to the effects of tobacco product use on the incidence of SARS-CoV-2 infection are inconsistent. However, evidence supports a role for cigarette smoking in increasing the risk of poor COVID-19 outcomes, including hospital admission, progression in disease severity, and COVID-19-related mortality. We discuss the potential effects of tobacco use behaviour on SARS-CoV-2 transmission and infection, and highlight the pathophysiological changes associated with cigarette smoking that could promote SARS-CoV-2 infection and increased disease severity. We consider the biological mechanisms by which nicotine and other tobacco product constituents might affect immune and inflammatory responses to SARS-CoV-2 infection. Finally, we identify current knowledge gaps and suggest priorities for research to address acute and post-acute health outcomes of COVID-19 during and after the pandemic.
 

Find more Research in our Newsroom or go back to top.


Job and Conference Announcements

If you have any job openings that would interest tobacco control professionals, please send them to us at naqc@naquitline.org.

NAQC is Seeking a President & CEO.
The North American Quitline Consortium (NAQC) is a non-profit membership organization that seeks to promote evidence based quitline services across diverse communities in North America. NAQC’s membership is made-up of over 400 organizations and individuals that provide quitline services, fund quitlines, conduct research around quitline-related topics, advance national cessation policies, and work in other areas of tobacco control.

NAQC is looking for a visionary and strategic leader who will reach audiences in creative, transformative and relevant new ways. The CEO will be knowledgeable about new technologies for marketing and delivering services as the landscape for tobacco cessation continues to evolve. The CEO will continue to use evidence based research while pushing the envelope to increase quitline participation.
 
The CEO’s responsibilities include finance and fundraising, strategic planning, board support, partnership activities, policy development and advocacy, spokesperson activities, security, and oversight of program and membership services (communications, policy, research and training). NAQC is centered in equity and the CEO will espouse these values internally, to members and externally.
The position is remote. Some travel is expected for partnership and spokesperson activities.
 
Please find the full job description and instructions on how to apply here.

CDC Job Opportunity: OSH Deputy Director for Research Translation.
National Center for Chronic Disease and Health Promotion (NCCDPHP)
Office on Smoking and Health (OSH), Office of the Director
Deputy Director for Research Translation
Senior Biomedical Research and Biomedical Product Assessment Service (SBRBPAS)
Opening Date: August 22, 2022
Closing Date: October 3, 2022

The Office on Smoking and Health (OSH) Office of the Director is seeking a dynamic and experienced candidate to serve as Deputy Director for Research Translation (DDRT).  This is an Excepted Service position in the Senior Biomedical Research and Biomedical Product Assessment Service (SBRBPAS). This job is open to the public (U.S. Citizens only), including current federal employees.    
 
OSH is the lead federal agency for comprehensive tobacco prevention and control focusing on four major goals: 1) prevent initiation of tobacco use among youth and young adults; 2) promote quitting among adults and youth; 3) eliminate exposure to secondhand smoke; and 4) advance health equity by identifying and eliminating commercial tobacco product-related disparities and inequities. With this foundation, OSH saves lives and money by preventing and reducing commercial tobacco use—the leading cause of preventable disease, disability, and death in the United States.
 
OSH provides primary staffing and scientific leadership to the Office of the Surgeon General (SG) to develop and publish the SG Reports on Tobacco and Health. The DDRT will lead the development of these SG Reports, a critical mechanism for translating the scientific literature into population-level commercial tobacco control, and highly respected evidence summaries to inform and guide regulatory and policy priorities.
 
Major Duties:
  • Provides scientific leadership in the field of biomedical research, including behavioral research.
  • Provides senior scientific leadership to coordinate and lead expert scientists in the development, and peer and senior scientific review of high impact tobacco-related scientific reports.
  • Cultivates collaborative partnerships that involve high priority projects with the potential for significant public health impact.
  • Provides scientific leadership in the evaluation of high impact public health tobacco control strategies and the dissemination of data on these strategies in reports, scientific publications, and major technical reports and guidance documents.
  • Provides strategic direction on policies, programmatic activities, partnerships, innovative data and analytic approaches, management, and operations for health equity and social determinants of health.
  • Provides senior scientific leadership and guidance on global, national or state/local tobacco surveillance systems, improving the quality and implementation of survey protocols, preparing country fact sheets and reports, country survey results, and integrating tobacco questions into other national surveillance systems.
For more information, and to apply, visit:  USAJOBS - Job Announcement
 
We encourage you to share this announcement with all who may be interested.  For questions related to this job announcement, you may contact Dr. Letitia Presley-Cantrell at lrp0@cdc.gov

Job Opportunities at the MaineHealth Center for Tobacco Independence- Remote/Hybrid Work Opportunity!
CTI is hiring two Tobacco Treatment and Prevention Educators. These full time, 32 hour a week positions will be an integral part of the Training and Education Team.

This position assists in the development, implementation and delivery of virtual and in person trainings to support the needs of healthcare professionals and prevention partners throughout the state of Maine with the goal of improving access to high quality, best practice tobacco treatment. This position will provide technical assistance and capacity building regarding options for treatment protocols and collaborate and coordinate with partner organizations. The role will contribute to, develop and maintain tobacco related resources and materials to support program growth and development. In addition this position will provide trainings and workshops to community healthcare professionals, employers and schools. Learn more. 

September 27-29, 2022: Exciting Youth Leadership Opportunity! 2022 Youth Menthol Convening.
This Fall, Truth Initiative will be hosting the “Finishing the Fight '' Youth Menthol Convening, which will be the youth-centered pre-conference to the 3rd National Menthol Conference. This convening is presented in partnership with the African American Tobacco Control Leadership Council (AATCLC). 
 
Truth Initiative is currently looking for passionate and committed student leaders who want to make an impact and are interested in learning about the current state of public health for the Black community, other impacted populations and how to “Finish the Fight” through using their voice through advocacy. 
 
Here’s what you need to know: 
  • Location: Marriott Marquis | Washington, DC 
  • Dates: September 27th- 29th, 2022
  • Cost: Truth Initiative will cover the cost of transportation, lodging and meals for all accepted student participants. 

Find more Job and Conference Announcements in our Newsroom or go back to top.


Funding for Connections is provided solely through a cooperative agreement from the Centers for Disease Control and Prevention (5 NU58DP006704-03-00). We thank them for their support of this publication. Information and links are provided solely as a service to NAQC members and partners and do not constitute an endorsement of any organization by NAQC, nor should any be inferred.